Archive for the ‘monoclonal_antibodies’ tag
Enbrel web banner
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Enbrel web banner
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Enbrel web banner
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Raptiva – bridge
Designed to last
Enduring efficacy in Psoriasis.
Raptiva has a proven favorable safety profile with more than 10 years clinical experience in psoriasis.
Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a medication designed to treat psoriasis. As its name implies, it is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection. It acts to inhibit white blood cell migration out of blood vessels into tissues. Because it suppresses the immune system, it has been associated with fatal brain infections, and has been withdrawn from the market.
Brand name: Raptiva
Generic name/category: Efalizumab, Monoclonal antibodies, Recombinant proteins, Immunosuppressants, Withdrawn drugs
Company: Merck Serono
Country/Market: UK, Europe
Indication(s)/use: Psoriasis
Target: Healthcare Professionals (HCP)
Tagline: Enduring disease reduction
Medium: Print ad
Size/duration: single-page
0 views
Aug 17, 2009
Visit AdPharm.net for more pharmaceutical ads
